EUVIMEDEUVIMED entdecken
Crossref

Albumin and Platelet Loss during the Application of CytoSorb ® in Critically Ill Patients: A post hoc Analysis of the Cyto-SOLVE Trial

Clara Isabell Brozat, Michael Zoller, Sandra Frank, Mathias Bruegel, Caroline Gräfe, Diana Rebholz, Michael Paal, Helen Graf, Uwe Liebchen, Christina Scharf

Blood Purification · 2024

DOI: 10.1159/000542009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Purification, 2024. Verfasst von Clara Isabell Brozat und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, LMU University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Blood Platelets, Continuous Renal Replacement Therapy, Serum Albumin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Adsorption devices like CytoSorb® (CS) are increasingly used in critically ill patients. However, potential adverse effects have not been sufficiently investigated. The aim of this post hoc analysis of the monocentric prospective Cyto-SOLVE study was to examine albumin concentration and platelet count during the application of CS in intensive care unit (ICU) patients with different indications for CS therapy.

Methods

Twenty-nine adult ICU patients receiving continuous kidney replacement therapy and CS application for 12 h were included. Albumin concentration and platelet count were measured before, during, and after application. Changes in albumin concentration and platelet count were investigated. Since 10/29 patients were substituted with platelets during CS therapy and 20/29 received albumin, subgroup analysis was performed in patients receiving no platelet concentrate and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsContinuous Renal Replacement TherapySerum AlbuminHumansCritical IllnessMaleFemaleMiddle AgedAgedPlatelet CountProspective StudiesIntensive Care UnitsAlbuminsAdult

Stichwörter der Autor:innen

AlbuminBlood componentsCritically ill patientsCytoSorb®Platelet

Substanzen

Serum AlbuminAlbumins

Autor:innen und Institutionen

  • Department of Anaesthesiology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Institute of Laboratory Medicine, LMU University Hospital, LMU Munich, Munich, Germany.

Zitieren

APA

Brozat, C. I., Zoller, M., Frank, S., Bruegel, M., Gräfe, C., Rebholz, D., Paal, M., Graf, H., Liebchen, U., & Scharf, C. (2024). Albumin and Platelet Loss during the Application of CytoSorb ® in Critically Ill Patients: A post hoc Analysis of the Cyto-SOLVE Trial. Blood Purification. https://doi.org/10.1159/000542009

Vancouver

Brozat CI, Zoller M, Frank S, Bruegel M, Gräfe C, Rebholz D, et al. Albumin and Platelet Loss during the Application of CytoSorb ® in Critically Ill Patients: A post hoc Analysis of the Cyto-SOLVE Trial. Blood Purification. 2024. doi:10.1159/000542009

BibTeX
@article{Brozat2024,
  author = {Brozat, Clara Isabell and Zoller, Michael and Frank, Sandra and Bruegel, Mathias and Gräfe, Caroline and Rebholz, Diana and Paal, Michael and Graf, Helen and Liebchen, Uwe and Scharf, Christina},
  title = {Albumin and Platelet Loss during the Application of CytoSorb ® in Critically Ill Patients: A post hoc Analysis of the Cyto-SOLVE Trial},
  journal = {Blood Purification},
  year = {2024},
  doi = {10.1159/000542009}
}
Kostenlos starten →